PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
202.89%
Net income growth above 1.5x AVGO's 66.48%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-4.95%
Negative yoy D&A while AVGO is 7.89%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
34.27%
Some yoy growth while AVGO is negative at -73.81%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
14.56%
SBC growth while AVGO is negative at -7.90%. John Neff would see competitor possibly controlling share issuance more tightly.
-119.25%
Both reduce yoy usage, with AVGO at -333.92%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-1085.32%
Both yoy AR lines negative, with AVGO at -129.21%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-47.88%
Negative yoy inventory while AVGO is 685.71%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
6972.73%
A yoy AP increase while AVGO is negative at -25.68%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
200.52%
Growth well above AVGO's 63.92%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-530.00%
Negative yoy while AVGO is 3696.86%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
118.07%
Some CFO growth while AVGO is negative at -4.88%. John Neff would note a short-term liquidity lead over the competitor.
-16.53%
Both yoy lines negative, with AVGO at -8.20%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
366.27%
Acquisition spending well above AVGO's 97.80%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
9.25%
Some yoy expansion while AVGO is negative at -353.85%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
3.46%
We have some liquidation growth while AVGO is negative at -52.81%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
3.17%
Less 'other investing' outflow yoy vs. AVGO's 120.00%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
46.97%
Lower net investing outflow yoy vs. AVGO's 97.23%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-378.93%
We cut debt repayment yoy while AVGO is 93.12%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-100.00%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-504.93%
We cut yoy buybacks while AVGO is 81.33%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.